A. Mamtani

发表

How Often Does Neoadjuvant Chemotherapy Avoid Axillary Dissection in Patients With Histologically Confirmed Nodal Metastases? Results of a Prospective Study

G. Plitas, H. Cody, M. Morrow, 2016, Annals of Surgical Oncology.

Nuclear Stat5a/b predicts early recurrence and prostate cancer-specific death in patients treated by radical prostatectomy.

B. Leiby, M. Nevalainen, P. Stattin, 2013, Human pathology.

Age and Receptor Status Do Not Indicate the Need for Axillary Dissection in Patients with Sentinel Lymph Node Metastases

H. Cody, M. Morrow, M. Pilewskie, 2016, Annals of Surgical Oncology.

Early-Stage Breast Cancer in the Octogenarian: Tumor Characteristics, Treatment Choices, and Clinical Outcomes

A. Recht, P. Slanetz, A. Mamtani, 2016, Annals of Surgical Oncology.

Early Adoption of the SSO-ASTRO Consensus Guidelines on Margins for Breast-Conserving Surgery with Whole-Breast Irradiation in Stage I and II Invasive Breast Cancer: Initial Experience from Memorial Sloan Kettering Cancer Center

M. Morrow, A. Eaton, M. Stempel, 2016, Annals of Surgical Oncology.

The Effect of Age on Outcomes After Neoadjuvant Chemotherapy for Breast Cancer

M. Morrow, T. D’alfonso, V. Sevilimedu, 2022, Annals of Surgical Oncology.

ASO Author Reflections: Refining Risk Assessment in Node-Positive Breast Cancer Patients Eligible for Sentinel Lymph Node Biopsy Alone

M. Morrow, A. Mamtani, 2020, Annals of Surgical Oncology.

Extranodal Tumor Deposits in the Axillary Fat Indicate the Need for Axillary Dissection Among T1–T2cN0 Patients with Positive Sentinel Nodes

M. Morrow, D. Goldman, A. Mamtani, 2020, Annals of Surgical Oncology.

Is Routine Axillary Imaging Necessary in Clinically Node-Negative Patients Undergoing Neoadjuvant Chemotherapy?

M. Morrow, A. Eaton, M. Stempel, 2017, Annals of Surgical Oncology.

How Often Is Treatment Effect Identified in Axillary Nodes with a Pathologic Complete Response After Neoadjuvant Chemotherapy?

M. Morrow, M. Murray, A. Eaton, 2016, Annals of Surgical Oncology.

Selecting Node-Positive Patients for Axillary Downstaging with Neoadjuvant Chemotherapy

E. Brogi, M. Morrow, A. Knezevic, 2020, Annals of Surgical Oncology.

Pleomorphic lobular carcinoma in situ of the breast: a single institution experience with clinical follow-up and centralized pathology review

Melissa P. Murray, E. Brogi, T. King, 2017, Breast Cancer Research and Treatment.

Lobular Breast Cancer: Different Disease, Different Algorithms?

T. King, A. Mamtani, 2018, Surgical oncology clinics of North America.

Adoption of SSO-ASTRO Margin Guidelines for Ductal Carcinoma in Situ: What Is the Impact on Use of Additional Surgery?

M. Morrow, R. Baser, M. Gemignani, 2020, Annals of Surgical Oncology.

Pathologic Complete Response with Neoadjuvant Doxorubicin and Cyclophosphamide Followed by Paclitaxel with Trastuzumab and Pertuzumab in Patients with HER2-Positive Early Stage Breast Cancer: A Single Center Experience.

C. Hudis, L. Norton, J. Baselga, 2017, The oncologist.

Lobular Histology Does Not Predict the Need for Axillary Dissection Among ACOSOG Z0011-Eligible Breast Cancers

M. Morrow, E. Zabor, M. Stempel, 2019, Annals of Surgical Oncology.

Abdominal compartment syndrome in trauma resuscitation

A. Kirkpatrick, S. Rizoli, S. Scarpelini, 2010, Current opinion in anaesthesiology.

Unplanned readmissions following breast cancer surgery.

T. James, A. Mamtani, G. Kasumova, 2019, American journal of surgery.

ASO Author Reflections: Avoiding Overtreatment: Benefits of Selective Use of Frozen Sections Among cN0 Breast Cancer Patients Having Upfront Mastectomy

A. Mamtani, Austin D. Williams, 2022, Annals of Surgical Oncology.

Omission of Intraoperative Frozen Section May Reduce Axillary Overtreatment Among Clinically Node-Negative Patients Having Upfront Mastectomy

M. Morrow, V. Sevilimedu, Atif J. Khan, 2022, Annals of Surgical Oncology.

Targeted Therapy and Local Control: The Dynamic Duo

T. King, A. Mamtani, 2017, Annals of Surgical Oncology.

Treatment Strategies in Octogenarians with Early-Stage, High-Risk Breast Cancer

A. Recht, A. Mamtani, M. Hacker, 2018, Annals of Surgical Oncology.

ASO Author Reflections: Heroic Mastectomy for Chemoresistant Disease: A Complex Decision

M. Morrow, A. Mamtani, 2021, Annals of Surgical Oncology.

Nodal Recurrence in Patients With Node-Positive Breast Cancer Treated With Sentinel Node Biopsy Alone After Neoadjuvant Chemotherapy-A Rare Event.

G. Plitas, M. Morrow, V. Sevilimedu, 2021, JAMA oncology.

ASO Author Reflections: Early-Stage Lobular Breast Cancer: Axillary Treatment in the Z0011 Era

M. Morrow, A. Mamtani, 2019, Annals of Surgical Oncology.

Is Clinical Exam of the Axilla Sufficient to Select Node-Positive Patients Who Downstage After NAC for SLNB? A Comparison of the Accuracy of Clinical Exam Versus MRI

M. Morrow, E. Zabor, M. Stempel, 2019, Annals of Surgical Oncology.

Axillary Dissection and Nodal Irradiation Can Be Avoided for Most Node-positive Z0011-eligible Breast Cancers: A Prospective Validation Study of 793 Patients

G. Plitas, H. Cody, M. Morrow, 2017, Annals of surgery.

The Optimal Treatment Plan to Avoid Axillary Lymph Node Dissection in Early-Stage Breast Cancer Patients Differs by Surgical Strategy and Tumor Subtype

M. Morrow, E. Zabor, M. Stempel, 2017, Annals of Surgical Oncology.

Do non-classic invasive lobular carcinomas derive a benefit from neoadjuvant chemotherapy?

M. Morrow, V. Sevilimedu, M. Gemignani, 2022, Breast Cancer Research and Treatment.

Why Are There So Many Mastectomies in the United States?

M. Morrow, A. Mamtani, 2017, Annual review of medicine.

Margin Width and Local Recurrence in Patients Undergoing Breast Conservation After Neoadjuvant Chemotherapy

M. Morrow, V. Sevilimedu, A. Mamtani, 2021, Annals of Surgical Oncology.

Do Calcifications Seen on Mammography After Neoadjuvant Chemotherapy for Breast Cancer Always Need to Be Excised?

M. Morrow, M. Stempel, M. Jochelson, 2017, Annals of Surgical Oncology.

Local Recurrence is Frequent After Heroic Mastectomy for Classically Inoperable Breast Cancers

M. Morrow, V. Sevilimedu, A. Mamtani, 2021, Annals of Surgical Oncology.

Are there patients with T1 to T2, lymph node‐negative breast cancer who are “high‐risk” for locoregional disease recurrence?

M. Morrow, M. Stempel, A. Mamtani, 2017, Cancer.

Abstract P3-13-07: Are there patients with T1-T2, node-negative breast cancer who are high-risk for locoregional recurrence?

M. Morrow, M. Stempel, A. Mamtani, 2017 .

Was Reexcision Less Frequent for Patients with Lobular Breast Cancer After Publication of the SSO-ASTRO Margin Guidelines?

M. Morrow, E. Zabor, M. Stempel, 2019, Annals of Surgical Oncology.

Impact of Age on Locoregional and Distant Recurrence After Mastectomy for Ductal Carcinoma In Situ With or Without Microinvasion

M. Morrow, E. Zabor, T. King, 2019, Annals of Surgical Oncology.

Is local recurrence higher among patients who downstage to breast conservation after neoadjuvant chemotherapy?

M. Morrow, V. Sevilimedu, A. Mamtani, 2021, Cancer.

Treatment of Ductal Carcinoma In Situ: Considerations for Tailoring Therapy in the Contemporary Era

A. Mamtani, K. V. Van Zee, 2020, Current Breast Cancer Reports.

Surgical Margins in Breast-Conserving Surgery

M. Morrow, A. Corben, A. Mamtani, 2019, Oncoplastic and Reconstructive Breast Surgery.

Diabetes insipidus uncovered during conservative management of complicated acute appendicitis

Kathryn L. Butler, A. Mamtani, S. Odom, 2016, Clinical case reports.

Axillary Micrometastases and Isolated Tumor Cells Are Not an Indication for Post-mastectomy Radiotherapy in Stage 1 and 2 Breast Cancer

M. Morrow, M. Stempel, A. Mamtani, 2017, Annals of Surgical Oncology.

Does a brief surgeon training in negotiation theory principles decrease rates of contralateral prophylactic mastectomy?

D. Malhotra, A. Vickers, D. Sjoberg, 2023, Breast Cancer Research and Treatment.

Impact of Age on Locoregional and Distant Recurrence After Mastectomy for Ductal Carcinoma In Situ With or Without Microinvasion

M. Morrow, E. Zabor, T. King, 2019, Annals of Surgical Oncology.

Mutational Status is Associated with a Higher Rate of Pathologic Complete Response After Neoadjuvant Chemotherapy in Hormone Receptor-Positive Breast Cancer

V. Sevilimedu, A. Mamtani, A. Barrio, 2023, Annals of Surgical Oncology.